Published date: Oct 30 2024

Journal Title: Dubai Medical Journal

Issue title: Dubai Medical Journal (DMJ): Volume 7 Issue 1

Pages: 9–15

DOI: 10.18502/dmj.v7i1.17495

Madhumita Nandimadhumitabanik@rediffmail.comDepartment of Pediatrics, North Bengal Medical College, Darjeeling, West Bengal

Nikhil GuptaDepartment of Pediatrics, North Bengal Medical College, Darjeeling, West Bengal

Introduction: Dengue is an endemic mosquito-borne infection in tropical countries. The manifestations vary from asymptomatic infection to classic dengue fever, to more critical forms like dengue hemorrhagic fever and dengue shock syndrome. The critical phase occurs typically within the timeline of 4-7 days from the onset of symptoms.

Case Report: We, hereby, report the case of a 7-year-old girl child who initially recovered from classic dengue fever. However, she was readmitted 18 days after the onset of initial symptoms with major bleeding manifestations due to immune thrombocytopenia responding to intravenous immunoglobulin.

Discussion: Dengue fever may be associated with mild to moderate thrombocytopenia in the febrile phase and moderate to severe thrombocytopenia in the critical phase. Here, the index case developed thrombocytopenia much after the expected critical phase was over.

Conclusion: Awareness of this possibility and continued monitoring, even after apparent recovery from dengue, is important for detecting and managing late-onset thrombocytopenia.

Keywords: dengue fever, immune thrombocytopenia, child

[1] World Health Organization. Regional Office for South-East Asia. Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded edition. WHO Regional Office for South-East. 2011. Asia. https://iris.who.int/handle/10665/204894

[2] Ministry of Health and Family Welfare, Government of India. National Guidelines for Clinical Management of Dengue Fever. National Center for Vector Borne Diseases Control 22-Shamnath Marg, New Delhi-110054 (Directorate General of Health Services) Ministry of Health & Family Welfare, Government of India. 2023.

[3] Alassri R, Martini N, Othman R, Kamil H, Mahmoud J. Thrombocytopenia with absent radii syndrome with delayed presentation of thrombocytopenic episodes: A case report. Ann Med Surg (Lond). 2023 Apr;85(5):2081–2084.

[4] Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Best Pract Res Clin Haematol. 2000 Jun;13(2):261–276.

[5] Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: Pathogenic and clinical diversity. Blood. 2009 Jun;113(26):6511–6521.

[6] de Souza LJ, Neto CG, Bastos DA, da Silva Siqueira EW, Ribeiro Nogueira RM, da Costa Carneiro R, et al. Dengue and immune thrombocytopenic purpura. Dengue Bull. 2005;29:136–141.

[7] Thadchanamoorthy V, Dayasiri K. Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura—a pediatric case report. Trop Med Health. 2020;48:59.

[8] Prashanth GP, Mugali SB. Persistent thrombocytopenia in dengue hemorrhagic fever. Indian Pediatr. 2011 Sep;48(9):737.

[9] Boo YL, Lim SY, P’ng HS, Liam C, Huan NC. Persistent thrombocytopenia following dengue fever: What should we do? Malays Fam Physician. 2019 Dec;14(3):71–73.

[10] Ramírez-Fonseca T, Segarra-Torres A, Jaume-Anselmi F, Ramírez-Rivera J. Dengue fever: A rare cause of immune thrombocytopenia. Bol Asoc Med P R. 2015;107(2):51–53.

[11] Ashrudin NA, Yin CE. Dengue fever as a rare cause of immune thrombocytopenic purpura-A Paediatric case report. BMJ Paediatr Open. 2021;5 Suppl 1:A1–132.